737 Followers on Owler

Tris Pharma

Read more
Ketan Mehta's photo - President & CEO of Tris Pharma

President & CEO

Ketan Mehta

CEO Approval Rating

91/100

Founded:

2000

Status:

PrivateIndependent Company

Est. Annual Revenue
$102M
Agree?
Est. Employees
500
Agree?

TRIS PHARMA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Tris Pharma's company profile
Ketan Mehta's photo - President & CEO of Tris Pharma

Ketan Mehta

President & CEO

91/100
500
$130M
$102M
View Profile
1
Tris Pharma's Competitor - Iroko logo
Louis J. Vollmer's photo - President & CEO of Iroko

Louis J. Vollmer

President & CEO

85/100
50
$215M
$50M
View Profile
2
Tris Pharma's Competitor - Alvogen logo
Robert Wessman's photo - Chairman & CEO of Alvogen

Robert Wessman

Chairman & CEO

83/100
2,800
- -
$1B
View Profile
3
Tris Pharma's Competitor - Knipper logo
Michael Laferrera's photo - President & CEO of Knipper

Michael Laferrera

President & CEO

- -
300
- -
$20.4M
View Profile
4
Tris Pharma's Competitor - Amneal logo
Chintu Patel's photo - Co-CEO of Amneal

Chintu Patel

Co-CEO

77/100
6,000
$250M
$2.1B
View Profile
5
Tris Pharma's Competitor - Purdue Pharma L.P. logo
Craig Landau's photo - President & CEO of Purdue Pharma L.P.

Craig Landau

President & CEO

66/100
5,000
- -
$3B
View Profile
6
Tris Pharma's Competitor - Lundbeck logo
Deborah Dunsire's photo - President & CEO of Lundbeck

Deborah Dunsire

President & CEO

85/100
5,551
- -
$2.9B
View Profile
7
Tris Pharma's Competitor - Alkermes logo
Richard Pops's photo - Chairman & CEO of Alkermes

Richard Pops

Chairman & CEO

76/100
2,245
$250M
$1.1B
View Profile
8
Tris Pharma's Competitor - Spine-health logo
Stephanie Burke's photo - Co-Founder & CEO of Spine-health

Stephanie Burke

Co-Founder & CEO

82/100
21
- -
$5M
View Profile
9
Tris Pharma's Competitor - Otsuka  logo
Tatsuo Higuchi's photo - President & CEO of Otsuka

Tatsuo Higuchi

President & CEO

86/100
32,992
- -
$13.8B
View Profile
10
Tris Pharma's Competitor - Vertex logo
Reshma Kewalramani's photo - President & CEO of Vertex

Reshma Kewalramani

President & CEO

82/100
1,100
$443M
$306.1M
View Profile
11
Tris Pharma's Competitor - Teva USA logo
CEO Avatar

Bill Marth

President & CEO

72/100
122
- -
$9.8M
View Profile
12
Tris Pharma's Competitor - PENNSAID logo
CEO Avatar

CEO

- -
50
- -
$4M
View Profile

Missing a competitor? Contribute!

Iroko is the top competitor of Tris Pharma. Iroko is a Private company that was founded in Philadelphia, Pennsylvania in 2007. Like Tris Pharma, Iroko also operates in the Pharmaceuticals sector. Iroko has 450 fewer employees vs. Tris Pharma.

Alvogen is seen as one of Tris Pharma's biggest rivals. Alvogen was founded in Morristown, New Jersey} in 2009. Like Tris Pharma, Alvogen also competes in the Pharmaceuticals space. Compared to Tris Pharma, Alvogen generates $898M more revenue.

Knipper is perceived as one of Tris Pharma's biggest rivals. Knipper was founded in 1986, and is headquartered in Lakewood, New Jersey. Knipper operates in the Business Support Services industry. Knipper generates $81.6M less revenue vs. Tris Pharma.

Tris Pharma Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Park Therapeutics, Inc.

Apr 2021

Source »
undisclosed
Park Therapeutics is a New Jersey-based pharmaceutical company that develops investigational drugs for the treatment of chronic pain.
NextWave Pharmaceuticals, Inc.

Sep 2018

Source »
undisclosed
NextWave Pharmaceuticals researches, develops and commercializes drugs for the treatment of attention deficit hyperactivity disorder.

These are all the companies that Tris Pharma has acquired. Tris Pharma has acquired 2 companies and its latest acquisition was Park Therapeutics, Inc. in Apr 2021. Park Therapeutics is a New Jersey-based pharmaceutical company that develops investigational drugs for the treatment of chronic pain.

Tris Pharma Funding History

Since Tris Pharma was founded in 2000, it has participated in 2 rounds of funding. In total Tris Pharma has raised $130.0M. Tris Pharma's last funding round was on Apr 2020 for a total of $5.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
Apr 2020
$5M - $10M

Since Tris Pharma was founded in 2000, it has participated in 2 rounds of funding. In total Tris Pharma has raised $130.0M. Tris Pharma's last funding round was on Apr 2020 for a total of $5.0M

Tris Pharma Investments

No recent investments found related to Tris Pharma

Tris Pharma News

December 18, 2020Markets Insider

Tris Pharma Hires Seasoned Research & Development Executive

MONMOUTH JUNCTION, N.J., Dec. 18, 2020 /PRNewswire/ -- Tris Pharma, Inc. ('Tris'), a specialty pharma... See more »
December 9, 2020BioSpace

Tris Pharma and Neuraxpharm Group Announce Partnership to Commercialize Tris' Quillivant XR and Quillichew ER in Europe

Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of FDA-approve... See more »
December 1, 2020Drug Store News

U.S. District Court upholds validity of Tris Pharma's Quillivant XR patents

The U.S. District Court of Delaware's decision prevents Actavis from launching generic versions of Qu... See more »
November 17, 2020Benzinga

Tris Pharma and Medison Pharma Announce Exclusive License Agreement to Commercialize Tris' Quillivant XR in Israel

MONMOUTH JUNCTION, NJ. and PETACH TIKVA, Israel, Nov. 17, 2020 /PRNewswire/ -- Tris Pharma, Inc. ("Tr... See more »
December 19, 2019roi-nj

Tris Pharma Inc. Announces Leadership Changes

Tris Pharma Inc., a specialty pharmaceutical company with a robust portfolio of approved products and... See more »

Tris Pharma Press Releases

December 18, 2020PR Newswire

Tris Pharma Hires Seasoned Research & Development Executive

MONMOUTH JUNCTION, N.J., Dec. 18, 2020 /PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharma... See more »
November 10, 2020PR Newswire

Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers

/PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfoli... See more »
October 22, 2020PR Newswire

Tris Pharma to Present Amphetamine Extended-Release Tablet Data at the Research Pipeline Session of 2020 American Academy of Child and Adolescent Psychiatry Meeting

MONMOUTH JUNCTION, N.J., Oct. 22, 2020 /PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharma... See more »
September 17, 2020PR Newswire

Tris Pharma Launches Redesigned Website for ADHD Healthcare Professionals

MONMOUTH JUNCTION, N.J., Sept. 17, 2020 /PRNewswire/ -- Tris Pharma, Inc. (Tris), a specialty pharmac... See more »
June 25, 2020StreetInsider

Tris Pharma Launches New Corporate Website

MONMOUTH JUNCTION, N.J., June 25, 2020 /PRNewswire/ --Â Tris Pharma, Inc. ("Tris"), a specialty pharm... See more »
March 17, 2020PR Newswire

Quillivant XR®, QuilliChew ER® and Dyanavel® XR are 100% Made in the U.S.A. and Remain Consistently Supplied During COVID-19 Pandemic

MONMOUTH JUNCTION, N.J., March 17, 2020 /PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharm... See more »
March 17, 2020StreetInsider

/C O R R E C T I O N -- Tris Pharma, Inc./

In the news release, Quillivant XR®, QuilliChew ER® and Dyanavel® XR are 100% Made in the U.S.A. a... See more »

Social Media

Tris Pharma Headquarters

2031 US Highway 130

Monmouth Junction, New Jersey08852

732-940-2800

Driving Directions »

Trending Companies

Tris Pharma Summary

ABOUT

Overview

Tris Pharma develops and commercializes OTC, Rx and specialty generic medicines. Tris Pharma was founded in 2000. Tris Pharma's headquarters is located in Monmouth Junction, New Jersey, USA 08852. It has raised 130.0M in 2 rounds. The latest round was...

CEO

Tris Pharma's President & CEO, Ketan Mehta, currently has an approval rating of 91%. Tris Pharma's primary competitors are Iroko, Alvogen & Knipper.

Frequently Asked Questions about Tris Pharma

  1. When was Tris Pharma founded?

    Tris Pharma was founded in 2000
  2. Who is Tris Pharma's CEO?

    Tris Pharma's CEO is Ketan Mehta
  3. How much revenue does Tris Pharma generate?

    Tris Pharma generates $102M in revenue
  4. How much funding does Tris Pharma have?

    Tris Pharma has historically raised $130M in funding
  1. Where is Tris Pharma's headquarters?

    Tris Pharma's headquarters is in Monmouth Junction New Jersey, USA
  2. How many employees does Tris Pharma have?

    Tris Pharma has 500 employees
  3. What sector does Tris Pharma operate in?

    Tris Pharma is in Pharmaceuticals
  4. Who are Tris Pharma's competitors?

    Tris Pharma's top competitors are Iroko, Alvogen, Knipper